↓ Skip to main content

Cochrane Database of Systematic Reviews

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
17 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
77 Mendeley
Title
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Published in
Cochrane database of systematic reviews, November 2022
DOI 10.1002/14651858.cd014384.pub2
Pubmed ID
Authors

Alessandro Rodolico, Spyridon Siafis, Irene Bighelli, Myrto T Samara, Wulf-Peter Hansen, Salvatore Salomone, Eugenio Aguglia, Pierfelice Cutrufelli, Ingrid Bauer, Lio Baeckers, Stefan Leucht

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 19%
Other 4 5%
Student > Bachelor 4 5%
Student > Ph. D. Student 3 4%
Professor > Associate Professor 3 4%
Other 10 13%
Unknown 38 49%
Readers by discipline Count As %
Medicine and Dentistry 22 29%
Nursing and Health Professions 5 6%
Neuroscience 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Psychology 2 3%
Other 4 5%
Unknown 39 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2023.
All research outputs
#2,301,398
of 25,462,162 outputs
Outputs from Cochrane database of systematic reviews
#4,798
of 12,766 outputs
Outputs of similar age
#48,500
of 488,382 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 75 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,766 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.5. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 488,382 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.